Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Fouillard

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Presse Medicale (Paris, France : 1983)|November 4, 1989
[Bone marrow autograft treated with mafosfamide in the acceleration phase in chronic myeloid leukemia. Inversion of the clinical development]L Fouillard, J Van Den Akker, J P Laporte, et al.
Leukemia|February 20, 2003
Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stromaL Fouillard, M Bensidhoum, D Bories, et al.
British Journal of Haematology|February 13, 2001
Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?O Ringdén, M Labopin, N C Gorin, et al.
Bone Marrow Transplantation|July 1, 1996
Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT)N C Gorin, M Labopin, L Fouillard, et al.
Bone Marrow Transplantation|May 1, 1997
Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis. Acute Leukaemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation (EBMT) and the International Marrow Unrelated Search and Transplant (IMUST) StudyO Ringdén, M Labopin, E Gluckman, et al.
Blood|November 5, 1997
Bone marrow versus peripheral blood progenitor cells CD34 selection in patients with non-Hodgkin's lymphomas: different levels of tumor cell reduction. Implications for autograftingM Lopez, F M Lemoine, H Firat, et al.
Experimental Hematology|January 21, 2000
Importance of marrow dose on posttransplant outcome in acute leukemia: models derived from patients autografted with mafosfamide-purged marrow at a single institutionN C Gorin, M Labopin, J P Laporte, et al.
Bone Marrow Transplantation|July 5, 2001
Improved efficiency of remission induction facilitates autologous BMT harvesting and improves overall survival in adults with AML: 108 patients treated at a single institutionF Isnard, M Guiguet, J P Laporte, et al.
Leukemia|July 20, 2007
Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry studyS Montoto, C Canals, A Z S Rohatiner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Autologous stem-cell transplantation for non-Hodgkin's lymphomas: the role of graft purging and radiotherapy posttransplantation--results of a retrospective analysis on 120 patients autografted in a single institutionL Fouillard, J P Laporte, M Labopin, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Presse Medicale (Paris, France : 1983)|November 4, 1989
[Bone marrow autograft treated with mafosfamide in the acceleration phase in chronic myeloid leukemia. Inversion of the clinical development]L Fouillard, J Van Den Akker, J P Laporte, et al.
Leukemia|February 20, 2003
Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stromaL Fouillard, M Bensidhoum, D Bories, et al.
British Journal of Haematology|February 13, 2001
Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?O Ringdén, M Labopin, N C Gorin, et al.
Bone Marrow Transplantation|July 1, 1996
Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT)N C Gorin, M Labopin, L Fouillard, et al.
Bone Marrow Transplantation|May 1, 1997
Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis. Acute Leukaemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation (EBMT) and the International Marrow Unrelated Search and Transplant (IMUST) StudyO Ringdén, M Labopin, E Gluckman, et al.
Blood|November 5, 1997
Bone marrow versus peripheral blood progenitor cells CD34 selection in patients with non-Hodgkin's lymphomas: different levels of tumor cell reduction. Implications for autograftingM Lopez, F M Lemoine, H Firat, et al.
Experimental Hematology|January 21, 2000
Importance of marrow dose on posttransplant outcome in acute leukemia: models derived from patients autografted with mafosfamide-purged marrow at a single institutionN C Gorin, M Labopin, J P Laporte, et al.
Bone Marrow Transplantation|July 5, 2001
Improved efficiency of remission induction facilitates autologous BMT harvesting and improves overall survival in adults with AML: 108 patients treated at a single institutionF Isnard, M Guiguet, J P Laporte, et al.
Leukemia|July 20, 2007
Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry studyS Montoto, C Canals, A Z S Rohatiner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Autologous stem-cell transplantation for non-Hodgkin's lymphomas: the role of graft purging and radiotherapy posttransplantation--results of a retrospective analysis on 120 patients autografted in a single institutionL Fouillard, J P Laporte, M Labopin, et al.
Pageof 6